Probiotics efficacy comparison
Pro Research Analysisby 
Searched over 200M research papers
Probiotics Efficacy Comparison: Single-Strain vs. Multi-Strain
Disease-Specific and Strain-Specific Efficacy of Probiotics
Research consistently shows that the effectiveness of probiotics depends heavily on both the specific strain used and the disease being treated. Some strains are effective for certain conditions, while others are not, even within the same species. For example, specific Lactobacillus and Bifidobacterium strains have demonstrated efficacy for preventing antibiotic-associated diarrhea and treating other gastrointestinal diseases, but not all strains within these genera are equally effective. This highlights the importance of considering both strain and disease specificity when selecting a probiotic product 815.
Single-Strain vs. Multi-Strain Probiotics: General Findings
Most studies indicate that, in many cases, single-strain probiotics are as effective as multi-strain mixtures for a variety of disease indications. The number of strains in a probiotic product does not automatically translate to greater efficacy. Instead, the choice should be based on evidence from clinical trials for the specific strain and disease in question. There is no strong evidence that multi-strain products are consistently superior, nor is there evidence of antagonistic effects between strains in combinations 14589.
Condition-Specific Comparisons
Gastrointestinal Diseases
Meta-analyses show that both single-strain and multi-strain probiotics can be effective in treating and preventing gastrointestinal diseases such as pouchitis, infectious diarrhea, irritable bowel syndrome, and Helicobacter pylori infection. However, the specific strain and disease matter more than whether the probiotic is single- or multi-strain. For example, Lactobacillus rhamnosus GG is particularly effective for antibiotic-associated diarrhea, while certain combinations may be more effective for H. pylori eradication 135789.
Preterm, Low Birth Weight Infants
In preterm, low birth weight infants, combinations of Lactobacillus and Bifidobacterium species have shown moderate to high-quality evidence for reducing all-cause mortality and severe necrotizing enterocolitis, outperforming single-strain products in these outcomes. Some single strains, such as Bifidobacterium animalis subsp. lactis and Lactobacillus reuteri, are also effective for specific outcomes like reducing hospitalization duration .
Metabolic and Inflammatory Outcomes in Pregnancy
For pregnant women, multi-strain probiotic combinations, especially those containing Lactobacillus acidophilus and Bifidobacterium, are more effective than single strains in improving glucose metabolism, lipid profiles, inflammation, and oxidative stress. Specific multi-strain combinations were ranked highest for reducing fasting blood sugar and insulin resistance, while certain single-strain combinations were best for lowering cholesterol and inflammation markers .
Type 2 Diabetes Management
Evidence for probiotics in type 2 diabetes management is mixed. Some studies show small improvements in glycemic control and cholesterol, but the effects are generally modest and not always clinically significant. There is no clear advantage of multi-strain over single-strain probiotics for these outcomes, and the overall certainty of evidence is low to moderate 610.
Practical Recommendations
- The choice between single-strain and multi-strain probiotics should be guided by clinical evidence for the specific strain and disease, not by the number of strains in the product 1458.
- For some conditions, such as certain gastrointestinal diseases and outcomes in preterm infants, specific multi-strain combinations may offer added benefits 237.
- Strain and disease specificity are critical; not all probiotics are interchangeable, and efficacy can vary widely even within the same species 81.
- More structured, head-to-head research is needed to clarify when multi-strain products offer true advantages over single-strain options .
Conclusion
The efficacy of probiotics is highly dependent on both the strain and the disease being targeted. While multi-strain combinations can be more effective for certain conditions, especially when specific strains are combined, single-strain probiotics are often equally effective for many indications. The most important factor in choosing a probiotic is the evidence supporting its use for the specific health outcome, rather than simply opting for products with more strains.
Sources and full results
Most relevant research papers on this topic